Charlie Howsare, MD MPH Pa. Viral Hepatitis Prevention Coordinator

Slides:



Advertisements
Similar presentations
HIV in the United Kingdom: 2013 HIV and AIDS Reporting Section Centre for Infectious Disease Surveillance and Control (CIDSC) Public Health England London,
Advertisements

HIV and Hepatitis C in non- MSM Rural Communities: Issues and Interventions Shari Wells-Weiss, CASAC Director of Prevention Services Southern Tier AIDS.
“Humanitarian Action” The Saint-Petersburg Charitable Foundation for Medical and Social Programs HAF.
HIV Prevention, treatment and care among people who inject drugs Fabienne Hariga, MD, MPH Senior HIV Adviser, UNODC Vienna.
Hepatitis and Liver Cancer A National Strategy for Prevention and Control of Hepatitis B and C.
Afghanistan’s Present IDUs-HIV/AIDS Situation and future action plan Dr.Saifur-Rehman NACP Director April,11,2007 Islamic Republic of Afghanistan Ministry.
Larry Cuellar Adult Viral Hepatitis Prevention Coordinator Texas Department of State Health Services 2010 STREET OUTREACH WORKERS CONFERENCE June 21, 2010.
Using HIV Surveillance to Achieve High Impact Prevention Irene Hall, PhD, FACE AIDS 2012 High-Impact Prevention: Reducing the HIV Epidemic in the United.
NURSETRI, Nursing role in HIV care : an overview Jane Bruton Clinical Research Nurse.
Pennsylvania: The State of HCV 2015
OVERVIEW OF PROJECT INSPIRE NYC Marie Bresnahan, MPH Project Director May 20,
Injection Drug Use and Hepatitis C What Can We Do About It? Wilson M. Compton, M.D., M.P.E. Deputy Director National Institute on Drug Abuse.
Decline in incidence of HIV and Hepatitis C virus infection among injecting drug users in Amsterdam; evidence for harm reduction? 1. Julius Center, University.
Hepatitis C: The Silent Epidemic Wednesday, October 21, 2015 John W. Ward, M.D. Division of Viral Hepatitis Centers for Disease Control and Prevention.
CURRENT HEALTH PROBLEMS IN STUDENT'S HOME SOUNTRIES HEPATITIS B IN MALAYSIA MOHD ZHARIF ABD HAMID AMINUDDIN BAKI AMRAN.
Jennifer R. Havens, PhD, MPH Associate Professor
Association for Women in Psychology Conference “A Model of Integrated Treatment for Women with Co-Occurring Disorders who are at High Risk for HIV” Presented.
Lessons Learned and Novel Investigation Techniques in Response to a Large Community Outbreak of HIV-1 infection Philip J. Peters MD HIV Testing and Biomedical.
Lessons from Indiana HIV and Hepatitis C Wisconsin HIV Community Planning Statewide Action Planning Group Meeting Green Lake June 25,
Non-Medical Staff Knowledge, Beliefs and Practices about HIV and Hepatitis for Injection Drug Users Rowe, KA 1, Tesoriero, JM 1, Heavner, KK 1, Rothman,
Template ID: junglegreens Size: 36x48 Impact of Hepatitis C Screening in Outpatient Population Madhuri Chandnani MD, Pallavi Pothuri MD, Michael Stevens.
Center for Studies of Addiction, University of Pennsylvania, USA
Hepatitis C Virus Program in Chicago
By: DR.Abeer Omran Consultant pediatric infectious disease
Addressing the Behavioral Health Needs of Cook County Residents
Addressing Viral Hepatitis
Pengjun Lu, PhD, MPH;1 Kathy Byrd, MD, MPH;2
Addressing the Intersection of Substance Abuse and Viral Hepatitis
WHO strategy on HIV/AIDS “Getting to Zero”
Entry into care Failure to initiate timely HIV care after diagnosis is common ~75% of newly diagnosed link to care within 6-12 months Delayed entry into.
6% of adults had used one or more illicit drugs in last 12 months.
10th Annual Susan Li Conference
Medication-Assisted Therapy at Coleman Profession Services
COLLECTIVE IMPACT APPROACH TO ADDRESSING
Marie P. Bresnahan, MPH, Mary M
Hepatitis C Incidence and Prevalence in the U.S.
Young People Newly Diagnosed with Hepatitis C in New York City
Opioids – A Pharmaceutical Perspective on Prescription Drugs
No one gets left behind: Addressing the hidden burden of hepatitis C related advanced liver disease in PWID in the community John S Lambert, MD, PhD.
Rowe, KA1, Tesoriero, JM1, Davis, SJ1, Heavner, KK1, Rothman, J2,
OPIOID SAFETY. Indiana Statistics In Summary… About 100 Hoosiers die from drug overdoses every month, many from opioids such as heroin and prescription.
Opioid Crisis A Call to ACTION
Viral Hepatitis in Correctional Settings
Jonathan Mermin, MD, MPH RADM, USPHS
Bloodborne viral and sexually transmissible infections in Aboriginal and Torres Strait Islander people Annual Surveillance Report 2017.
National Programme for limiting spread of HIV/AIDS in Latvia 2008–2012
RISK R isk of Perinatal and Early Childhood Infection
HCV Screening.
Needle exchange program
Community Advocacy for HCV: Identify, Link to Care, and Treat to Prevent.
Figure 1 Reporting of Aboriginal and Torres Strait Islander status at notification, for selected sexually transmissible infections, 2017, by state or territory.
Hepatitis C Tennessee Caring Ambassadors, Senate Briefing May 18, 2018
Pain Management and Substance Use Disorders: JCPP Strategic Session
ENDING THE EPIDEMICS: A FOCUS ON PEOPLE WHO INJECT DRUGS
PA Health Insurance Navigator Program
State Response to Opioids and Infectious Disease
Blood borne viral hepatitis action in Wales
German Drug and Addiction Policy
Professor Jack Lambert
Substance Use Prevention for Young Adults and Higher Education
Lesson 3: Treatment as Prevention
Strategic Initiatives to Address Opioid Overdose & Addiction
Human Dignity and Harm Reduction
Ingredients of a Sustainable healthcare SYSTEM– the Cayman islands experience Lizzette Yearwood.
Hepatitis C case-finding – An opportunity for community pharmacy
Can be personalized to individual group needs.
Managing Hepatitis C in Vermont
Share your thoughts on this presentation with #IAS2019
HUMAN IMMUNODEFICIENCY VIRUS (HIV) PREVENTION & CARE
March 8, 2006 New ACIP Hepatitis B Recommendations
Presentation transcript:

Charlie Howsare, MD MPH Pa. Viral Hepatitis Prevention Coordinator The Intersection of Overdose, Opiate Use Disorder, and HCV in Pennsylvania 2016 Charlie Howsare, MD MPH Pa. Viral Hepatitis Prevention Coordinator

This is the public health crisis of our generation.

The Epidemics Everyday in the Commonwealth: 10 people die of overdose >17 young adults contract hepatitis C Women infected with HCV, who do not know their status, are giving birth

Sentinel Events 400% increase in HCV in 4 States 2013 HIV/HCV Outbreak in Indiana 2014 Overdose deaths 2015 Tripling of heroin users 2016 150,000 to almost ½ a million

400% increase in HCV in 4 States 2013 Tennessee, Kentucky, Virginia, West Virginia Oral opiatesInjection of opiatesHeroin HCV prevalence in using networks 30-70%

HCV Infection from Injection Drug Use Behaviors Injection drug use (IDU) is the principle risk factor for HCV infection Most reported risk behavior in acute case reporting HCV prevalence among persons who inject drugs (PWID) between 30% and 70% HCV prevalence among younger (<30 yrs.) between 10% and 36% HCV incidence between 16% and 42% per year Hagan et al. 2010; Garfein et al. 1998; Armstrong et al. 2006; Amon et al. 2008; Klevens et al. 2013; Daniels et al. 2007

PA-NEDSS Reported HCV Past and Present by Age Group

Changes in Demographics PA 2003 2007

Changes in Demographics PA 2010 2014

GIS Mapping of HCV Age-Specific per 100,000 for the 15-35 year old demographic

HCV in Young Adults in Pennsylvania 2003-2015

190 people in this Indiana town were diagnosed with HIV April 10, 2016 “Now, a year later, the outbreak is at 190 cases. But the sickness runs deeper. Poverty envelops this city. Empty storefronts dot the main street. Many homes are boarded up or have makeshift tarps instead of windows. Fewer than 10% of Austin's residents have earned a college degree. One out of five residents lives below the poverty level, more than 1.5 times the rate in Indiana. Drug use here is still rampant.”

190 people in this Indiana town were diagnosed with HIV April 10, 2016 “Some users shoot up alongside their children or even their children’s children. In the winter, as many as 20 users may huddle in a home, gathering in the one building that has heat for the day.”

More Consequences On track with the heroin crisis, the number of children in foster care in Pennsylvania has leapt in three years, reaching 15,995 at the end of 2015, state statistics show. That’s a 14 percent increase from the 14,004 of 2012. In one of those years, 2014, parental substance abuse was a factor in more than 56 percent of the cases in which infants were removed from their homes, according to the Center for Children’s Justice, a nonprofit in Berks County. Alongside that, more than 7,500 babies were born from 2010 to 2014 with drug dependencies they received in utero, according to Pennsylvania Medicaid statistics obtained by the children’s justice center. And those were tip-of-the-iceberg numbers that do not account for newborns whose mothers had private insurance, as six in 10 Pennsylvanians do.

More Consequences 2691 babies required NICU stays in 2015 (788 required NICU stays in 2000) 60% of the babies required morphine or methadone to get through withdrawl 4615 maternal hospital stays related to substance abuse 2015 52% related to heroin Average length of stay for addicted babies is 25 days Source: PHC4

More Consequences For every 100 mothers who have hepatitis C, about six newborns will contract the disease, according to the Centers for Disease Control and Prevention [CDC]. Since transmission rates are low compared to hepatitis B or HIV, hospitals aren’t testing high-risk babies. 8,119 women were reported to Philadelphia’s Hepatitis Registry as HCV positive. Of those, 500 had at least one baby, with 537 total children born during the 2011 through 2013 study period. Just 84 of these children were tested. Four of them were confirmed cases of hepatitis C. Of the newborns who were not screened, roughly 24 other cases of the virus are expected to develop. But without testing, many will remain unaware of the condition and will not seek treatment until later in life.

Treating Opiate Addiction

Opiate Use Disorder

Opiate Use Disorder

Opiate Use Disorder

Opiate Use Disorder (OUD)

Opiate Use Disorder

Opiate Use Disorder

Overdose

OUD

Overdose

Overdose

Necessary but not sufficient…. Drug Treatment with MAT Methadone Suboxone Harm Reduction Syringe/works exchange Naloxone HCV treatment Reduce the viral load of the using community

Educational Materials

Vulnerability Assessment

Harm Reduction

Framework of a model HCV control strategy for PWID Prevent new infections Detect and care for existing infections Reduce chronic infections HCV prevention activities Access to syringes & other equipment OST Safe injection education Outreach to those not engaged Screening and diagnosis Antibody screening RNA test to confirm Clinical evaluation to determine disease stage Monitoring disease progression Reduce alcohol use HCV care and treatment Treat to cure infection Support adherence to treatment Support post-cure to prevent reinfection Co-locating these services increases their impact on HCV control Provided by Holly Hagan

Our Challenge How do we keep people alive, and uninfected with HBV, HCV, and HIV until they can get into drug treatment that allows treatment integrity and offers opiate substitution therapy with ongoing support through early recovery?

Summary Everyday in the Commonwealth: 10 people die of overdose >17 young adults contract hepatitis C Women infected with HCV, who do not know their status, are giving birth